Sterling Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Sell |
639
-1,515
| -70% | -$614K | 0.15% | 111 |
|
|
2025
Q1 | $1.07M | Buy |
2,154
+1,120
| +108% | +$557K | 0.37% | 51 |
|
|
2024
Q4 | $538K | Sell |
1,034
-1,135
| -52% | -$590K | 0.36% | 48 |
|
|
2024
Q3 | $1.34M | Buy |
2,169
+207
| +11% | +$128K | 0.48% | 42 |
|
|
2024
Q2 | $1.08M | Sell |
1,962
-44
| -2% | -$24.3K | 0.43% | 45 |
|
|
2024
Q1 | $1.17M | Buy |
2,006
+249
| +14% | +$145K | 0.54% | 39 |
|
|
2023
Q4 | $933K | Buy |
1,757
+136
| +8% | +$72.2K | 0.48% | 44 |
|
|
2023
Q3 | $821K | Buy |
1,621
+125
| +8% | +$63.3K | 0.47% | 43 |
|
|
2023
Q2 | $781K | Buy |
1,496
+53
| +4% | +$27.7K | 0.42% | 43 |
|
|
2023
Q1 | $832K | Buy |
1,443
+67
| +5% | +$38.6K | 0.49% | 38 |
|
|
2022
Q4 | $758K | Buy |
1,376
+4
| +0.3% | +$2.2K | 0.47% | 43 |
|
|
2022
Q3 | $695K | Buy |
1,372
+28
| +2% | +$14.2K | 0.51% | 36 |
|
|
2022
Q2 | $729K | Buy |
1,344
+145
| +12% | +$78.7K | 0.56% | 31 |
|
|
2022
Q1 | $708K | Buy |
1,199
+6
| +0.5% | +$3.54K | 0.48% | 35 |
|
|
2021
Q4 | $796K | Buy |
+1,193
| New | +$796K | 0.54% | 34 |
|